Experimental infection and protection against ... - TI Pharma

Long-term protection against malaria after experimental sporozoite inoculation 211
References
1. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001;
64: 85-96.
2. Morel CM, Lauer JA, Evans DB. Cost effectiveness analysis of strategies to
combat malaria in developing countries. BMJ 2005; 331: 1299.
3. Achtman AH, Bull PC, Stephens R, Langhorne J. Longevity of the immune
response and memory to blood-stage malaria infection. Curr Top Microbiol
Immunol 2005; 297: 71-102.
4. Doolan DL, Dobano C, Baird JK. Acquired immunity to malaria. Clin Microbiol
Rev 2009; 22: 13-36, Table.
5. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL et al. Protection of
humans against malaria by immunization with radiation-attenuated
Plasmodium falciparum sporozoites. J Infect Dis 2002; 185: 1155-64.
6. Crompton PD, Pierce SK, Miller LH. Advances and challenges in malaria vaccine
development. J Clin Invest 2010; 120: 4168-78.
7. Olotu A, Lusingu J, Leach A, Lievens M, Vekemans J, Msham S et al. Efficacy of
RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite
antibody titres and protection in children aged 5-17 months in Kenya and
Tanzania: a randomised controlled trial. Lancet Infect Dis 2011; 11: 102-9.
8. Sacarlal J, Aide P, Aponte JJ, Renom M, Leach A, Mandomando I et al. Long-term
safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.
J Infect Dis 2009; 200: 329-36.
9. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ et al.
Protection against a malaria challenge by sporozoite inoculation. N Engl J Med
2009; 361: 468-77.
10. Bousema JT, Roeffen W, van der KM, de Vlas SJ, van d, V, Bangs MJ et al. Rapid
onset of transmission-reducing antibodies in javanese migrants exposed to
malaria in Papua, Indonesia. Am J Trop Med Hyg 2006; 74: 425-31.
11. Ponnudurai T, Lensen AH, van Gemert GJ, Bensink MP, Bolmer M, Meuwissen
JH. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes.
Parasitology 1989; 98 Pt 2: 165-73.
12. Nieman AE, de MQ, Roestenberg M, Wiersma J, Pop G, Stalenhoef A et al.
Cardiac complication after experimental human malaria infection: a case report.
Malar J 2009; 8: 277.
13. de Mast Q, Groot E, Lenting PJ, de Groot PG, McCall M, Sauerwein RW et al.
Thrombocytopenia and release of activated von Willebrand Factor during early
Plasmodium falciparum malaria. J Infect Dis 2007; 196: 622-8.